pfizer inc (PFE:New York)
Former President of the Emerging Markets & Established Products Business Unit and General Manager of The Emerging Markets & Established Products Business Unit, Pfizer Inc.
|Age||Total Calculated Compensation||This person is connected to 40 board members in 2 different organizations across 6 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Olivier Brandicourt has been Chief Executive Officer at Sanofi since April 2015. Mr. Brandicourt served as Chief Executive Officer at Bayer HealthCare Pharmaceuticals Inc. since November 01, 2013. He served as the Chairman of the Management Board at Bayer HealthCare AG from November 1, 2013 to March 31, 2015 and Also served as its Chief Executive Officer. Mr. Brandicourt served as the President and General Manager, the Emerging Markets and Established Products Business ...
235 East 42nd StreetPhone: 212-733-2323
New York, New York 10017
Board Members Memberships*
Chief Executive Officer and Director
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Omar S. Ishrak||Chairman and Chief Executive Officer|
|Marijn E. Dekkers Ph.D.||Chairman of Management Board and Chief Executive Officer|
|Andrew Philip Witty||Chief Executive Officer, Executive Director and Member of Finance Committee|
|2.0M GBP||Compensation as of Fiscal Year 2014.|